Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments

Hillstream BioPharma, Inc., a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death for drug resistant and devastating cancers, today announced a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors. Immune Checkpoint Inhibitors and Ferroptosis Treatment with immune checkpoint inhibitors (ICIs) induces the effector function of T cells in the tumor microenvironment (TME). Activated T cells accumulated in TME then kill tumor cells mainly by enhancing cell death through the granzyme pathway and by releasing interferon gamma (IFN?) from CD8 + T cells. Ferroptosis is a newly defined form of cell death, that is different than apoptosis, necrosis or autophagy, and results from iron-dependent accumulation of lipid reactive oxygen species or lipid peroxidation. Recent studies published [Nature, 569 (7755):270-274, 2019] describe that immunotherapy-activated CD8 + T cells enhance ferroptosis-specific lipid peroxidation in tumor cells leading to the anti-tumor effect of immunotherapy. Activated CD8 + T cells by treatment with ICIs promote tumor cell lipid peroxidation and thereby sensitize tumor cells to ferroptosis inducers through IFN?. The study concluded that inducing the Ferroptotic pathway in combination with checkpoint blockade is a potential synergistic therapeutic approach.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!